Screening and follow-up treatment of 160 046 neonates with congenital adrenal hyperplasia in Ningxia, China.
- Author:
Xin-Mei MAO
1
;
Miao JING
;
Hai-Yan TIAN
Author Information
- Publication Type:Journal Article
- MeSH: Adrenal Hyperplasia, Congenital; diagnosis; epidemiology; therapy; China; epidemiology; Female; Follow-Up Studies; Humans; Infant, Newborn; Male; Prognosis
- From: Chinese Journal of Contemporary Pediatrics 2016;18(8):698-701
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the incidence of congenital adrenal hyperplasia (CAH) and treatment outcomes in neonates in Ningxia, China.
METHODSThe clinical data of CAH screening for 160 046 neonates who were born in midwifery institutions in Ningxia from July 2014 to March 2016 were analyzed.
RESULTSAmong the 160 046 neonates who underwent CAH screening, 70 (0.044%) obtained a positive result and 11 were diagnosed with CAH; the incidence rate of CAH was 1/14 550 (0.069‰). Among the 11 neonates diagnosed with CAH, 9 had the salt wasting type (2 died) and 2 had simple virilization. The 9 neonates were given glucocorticoids immediately once diagnosed and all of them achieved good growth and development.
CONCLUSIONSThe incidence of neonatal CAH in Ningxia is 1/14 550. It is very necessary to carry out CAH screening in Ningxia, and active treatment can improve the prognosis of neonates with CAH.
